Aspen Aerogels (NYSE:ASPN) Shares Cross Below Fifty Day Moving Average – Here’s Why

Aspen Aerogels, Inc. (NYSE:ASPN)’s share price passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $4.34 and traded as low as $2.88. Aspen Aerogels shares last traded at $2.9640, with a volume of 2,231,547 shares changing hands.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the stock. Barclays lowered their price objective on shares of Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating on the stock in a research report on Friday, November 7th. Zacks Research lowered Aspen Aerogels from a “hold” rating to a “strong sell” rating in a report on Monday, November 10th. Canaccord Genuity Group dropped their price target on Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating on the stock in a research report on Friday, November 7th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Aspen Aerogels in a research report on Monday, December 22nd. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, two have issued a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, Aspen Aerogels currently has an average rating of “Hold” and a consensus target price of $12.67.

Aspen Aerogels Trading Up 0.8%

The firm has a market capitalization of $244.97 million, a price-to-earnings ratio of -0.80 and a beta of 2.95. The business’s 50 day moving average price is $4.34 and its 200-day moving average price is $6.10. The company has a debt-to-equity ratio of 0.28, a current ratio of 3.94 and a quick ratio of 3.33.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings data on Thursday, November 6th. The construction company reported ($0.06) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.05). Aspen Aerogels had a negative net margin of 86.52% and a negative return on equity of 0.20%. The business had revenue of $73.02 million during the quarter, compared to analysts’ expectations of $73.42 million. During the same period in the prior year, the firm posted ($0.17) EPS. Aspen Aerogels’s revenue for the quarter was down 37.8% compared to the same quarter last year. Aspen Aerogels has set its FY 2025 guidance at -4.150–4.050 EPS. Equities analysts forecast that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, CEO Donald R. Young sold 56,845 shares of the company’s stock in a transaction on Thursday, November 13th. The stock was sold at an average price of $3.23, for a total transaction of $183,609.35. Following the transaction, the chief executive officer owned 494,011 shares of the company’s stock, valued at $1,595,655.53. This represents a 10.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 3.40% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Aspen Aerogels

Several institutional investors have recently made changes to their positions in the stock. Invesco Ltd. increased its holdings in shares of Aspen Aerogels by 42.8% in the 1st quarter. Invesco Ltd. now owns 72,631 shares of the construction company’s stock valued at $464,000 after purchasing an additional 21,760 shares in the last quarter. Nuveen LLC acquired a new position in Aspen Aerogels during the first quarter worth about $1,083,000. Trexquant Investment LP increased its holdings in Aspen Aerogels by 114.7% in the first quarter. Trexquant Investment LP now owns 860,246 shares of the construction company’s stock valued at $5,497,000 after buying an additional 459,582 shares in the last quarter. Baird Financial Group Inc. lifted its position in shares of Aspen Aerogels by 10.8% during the 1st quarter. Baird Financial Group Inc. now owns 444,280 shares of the construction company’s stock valued at $2,839,000 after acquiring an additional 43,149 shares during the period. Finally, Graham Capital Management L.P. boosted its stake in shares of Aspen Aerogels by 27.0% during the 1st quarter. Graham Capital Management L.P. now owns 166,959 shares of the construction company’s stock worth $1,067,000 after acquiring an additional 35,484 shares in the last quarter. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.